The Crosstalk between Myeloid Derived Suppressor Cells and Immune Cells: To Establish Immune Tolerance in Transplantation

Journal of Immunology Research

Volumn 2016, Issue , 2016, Pages

  Zhang, Chao ^a,b   Wang, Shuo ^a,b   Yang, Cheng ^a,b   Rong, Ruiming ^a,b  

^a FUDAN UNIVERSITY   (China)

^b Shanghai Key Laboratory of Organ Transplantation   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DENDRITIC CELL; GRAFT VERSUS HOST REACTION; HEART GRAFT; HUMAN; IMMUNOCOMPETENT CELL; KIDNEY GRAFT; MACROPHAGE; MYELOID DERIVED SUPPRESSOR CELL; NATURAL KILLER CELL; NATURAL KILLER T CELL; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; REGULATORY T LYMPHOCYTE; REVIEW; SKIN GRAFT; SUPPRESSOR CELL; TRANSPLANTATION TOLERANCE; ADAPTIVE IMMUNITY; ANIMAL; IMMUNOLOGY; MOUSE; MYELOID-DERIVED SUPPRESSOR CELL; SIGNAL TRANSDUCTION;

ADAPTIVE IMMUNITY; ANIMALS; DENDRITIC CELLS; HUMANS; KILLER CELLS, NATURAL; MACROPHAGES; MICE; MYELOID-DERIVED SUPPRESSOR CELLS; NATURAL KILLER T-CELLS; RECEPTOR CROSS-TALK; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION TOLERANCE;

EID: 84994430495     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2016/4986797     Document Type: Review

References (52)

1. P. Serafini, I. Borrello, and V. Bronte, "Myeloid suppressor cells in cancer: recruitment, phenotype, properties, andmechanisms of immune suppression, " Seminars in Cancer Biology, vol. 16, no. 1, pp. 53-65, 2006.
2. D. I. Gabrilovich, V. Bronte, S.-H. Chen et al., "The terminology issue for myeloid-derived suppressor cells, " Cancer Research, vol. 67, no. 1, pp. 425-426, 2007.
3. J.-I. Youn, S. Nagaraj, M. Collazo, andD. I. Gabrilovich, "Subsets of myeloid-derived suppressor cells in tumor-bearing mice, " Journal of Immunology, vol. 181, no. 8, pp. 5791-5802, 2008.
4. C. Bartmann, M. Junker, S. E. Segerer, S. F. Hausler, M. Krockenberger, and U. Kammerer, "CD33(+) /HLA-DR(neg) and CD33(+) /HLA-DR(+/-) cells: rare populations in the human decidua with characteristics of MDSC, " American Journal of Reproductive Immunology, vol. 75, no. 5, pp. 539-556, 2016.
5. S. Nagaraj, K. Gupta, V. Pisarev et al., "Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer, " Nature Medicine, vol. 13, no. 7, pp. 828-835, 2007.
6. P. C. Rodriguez, A. H. Zea, K. S. Culotta, J. Zabaleta, J. B. Ochoa, and A. C. Ochoa, "Regulation of T cell receptor CD3zeta chain expression by L-arginine, " The Journal of Biological Chemistry, vol. 277, no. 4, pp. 21123-21129, 2002.
7. P. C. Rodriguez, D. G. Quiceno, and A. C. Ochoa, "Larginine availability regulates T-lymphocyte cell-cycle progression, " Blood, vol. 109, no. 4, pp. 1568-1573, 2007.
8. Y. Sawanobori, S. Ueha, M. Kurachi et al., "Chemokinemediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice, " Blood, vol. 111, no. 12, pp. 5457-5466, 2008.
9. K. H. Parker, P. Sinha, L. A. Horn et al., "HMGB1 enhances immune suppression by facilitating the differentiation and suppressive activity of myeloid-derived suppressor cells, " Cancer Research, vol. 74, no. 20, pp. 5723-5733, 2014.
10. G. Egger, G. Liang, A. Aparicio, and P. A. Jones, "Epigenetics in human disease and prospects for epigenetic therapy, " Nature, vol. 429, no. 6990, pp. 457-463, 2004.
11. I. Vaknin, L. Blinder, L. Wang et al., "A common pathway mediated through Toll-like receptors leads to T-and natural killer-cell immunosuppression, " Blood, vol. 111, no. 3, pp. 1437-1447, 2008.
12. N. Nausch, I. E. Galani, E. Schlecker, and A. Cerwenka, "Mononuclear myeloid-derived 'suppressor' cells express RAE-1 and activate natural killer cells, " Blood, vol. 112, no. 10, pp. 4080-4089, 2008.
13. H. Q. Li, Y. M. Han, Q. L. Guo, M. G. Zhang, and X. T. Cao, "Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-1, " The Journal of Immunology, vol. 182, no. 1, pp. 240-249, 2009.
14. C.-E. Hu, J. Gan, R.-D. Zhang, Y.-R. Cheng, and G.-J. Huang, "Up-regulated myeloid-derived suppressor cell contributes to hepatocellular carcinoma development by impairing dendritic cell function, " Scandinavian Journal of Gastroenterology, vol. 46, no. 2, pp. 156-164, 2011.
15. C. E. Heim, D. Vidlak, T. D. Scherr et al., "Myeloid-derived suppressor cells contribute to staphylococcus aureus orthopedic biofilm infection, " Journal of Immunology, vol. 192, no. 8, pp. 3778-3792, 2014.
16. S. L. Lui, K. W. Chan, R. Tsang, S. Yung, K. N. Lai, and T. M. Chan, "Effect of rapamycin on renal ischemia-reperfusion injury in mice, " Transplant International, vol. 19, no. 10, pp. 834-839, 2006.
17. I. Poschke, Y. Mao, L. Adamson, F. Salazar-Onfray, G. Masucci, and R. Kiessling, "Myeloid-derived suppressor cells impair the quality of dendritic cell vaccines, " Cancer Immunology, Immunotherapy, vol. 61, no. 6, pp. 827-838, 2012.
18. V. Greifenberg, E. Ribechini, S. Rößner, and M. B. Lutz, "Myeloid-derived suppressor cell activation by combined LPS and IFN-treatment impairs DC development, " European Journal of Immunology, vol. 39, no. 10, pp. 2865-2876, 2009.
19. J. Rolinski and I. Hus, "Breaking immunotolerance of tumors: A new perspective for dendritic cell therapy, " Journal of Immunotoxicology, vol. 11, no. 4, pp. 311-318, 2014.
20. D. W. Beury, K. H. Parker, M. Nyandjo, P. Sinha, K. A. Carter, and S. Ostrand-Rosenberg, "Cross-talk amongmyeloid-derived suppressor cells, macrophages, and tumor cells impacts the inflammatory milieu of solid tumors, " Journal of Leukocyte Biology, vol. 96, no. 6, pp. 1109-1118, 2014.
21. S. Ostrand-Rosenberg, P. Sinha, D. W. Beury, and V. K. Clements, "Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression, " Seminars in Cancer Biology, vol. 22, no. 4, pp. 275-281, 2012.
22. A. Mantovani, A. Sica, P. Allavena, C. Garlanda, and M. Locati, "Tumor-associated macrophages and the related myeloidderived suppressor cells as a paradigm of the diversity of macrophage activation, " Human Immunology, vol. 70, no. 5, pp. 325-330, 2009.
23. S. Ostrand-Rosenberg and P. Sinha, "Myeloid-derived suppressor cells: linking inflammation and cancer, " Journal of Immunology, vol. 182, no. 8, pp. 4499-4506, 2009.
24. S. K. Bunt, V. K. Clements, E. M. Hanson, P. Sinha, and S. Ostrand-Rosenberg, "Inflammation enhances myeloid-derived suppressor cell cross-talk by signaling through Toll-like receptor 4, " Journal of Leukocyte Biology, vol. 85, no. 6, pp. 996-1004, 2009.
25. A. Thakur, D. Schalk, E. Tomaszewski et al., "Microenvironment generated during EGFR targeted killing of pancreatic tumor cells by ATC inhibits myeloid-derived suppressor cells through COX2 and PGE2 dependent pathway, " Journal of Translational Medicine, vol. 11, no. 1, article 35, 2013.
26. J.-S. Shin, M. Ebersold, M. Pypaert, L. Delamarre, A. Hartley, and I. Mellman, "Surface expression of MHC class II in dendritic cells is controlled by regulated ubiquitination, " Nature, vol. 444, no. 7115, pp. 115-118, 2006.
27. J. Thibodeau, M.-C. Bourgeois-Daigneault, G. Huppé et al., "Interleukin-10-induced MARCH1 mediates intracellular sequestration ofMHC class II in monocytes, " European Journal of Immunology, vol. 38, no. 5, pp. 1225-1230, 2008.
28. I. Marrero, R. Ware, and V. Kumar, "Type II NKT cells in inflammation, autoimmunity, microbial immunity, and cancer, " Frontiers in Immunology, vol. 6, article 316, 2015.
29. D. Slauenwhite and B. Johnston, "Regulation of NKT cell localization in homeostasis and infection, " Frontiers in Immunology, vol. 6, article 255, 2015.
30. M. Terabe, S. Matsui, J.-M. Park et al., "Transforming growth factor-production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic t lymphocyte-mediated tumor immunosurveillance: Abrogation prevents tumor recurrence, " Journal of Experimental Medicine, vol. 198, no. 11, pp. 1741-1752, 2003.
31. D. Hongo, X. Tang, J. Baker, E. G. Engleman, and S. Strober, "Requirement for interactions of natural killer T cells and myeloid-derived suppressor cells for transplantation tolerance, " American Journal of Transplantation, vol. 14, no. 11, pp. 2467-2477, 2014.
32. N. Safinia, C. Scotta, T. Vaikunthanathan, R. I. Lechler, and G. Lombardi, "Regulatory T cells: serious contenders in the promise for immunological tolerance in transplantation, " Frontiers in Immunology, vol. 6, article 438, 2015.
33. B. Huang, P.-Y. Pan, Q. Li et al., "Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumorinduced T regulatory cells and T-cell anergy in tumor-bearing host, " Cancer Research, vol. 66, no. 2, pp. 1123-1131, 2006.
34. M. R. Garcia, L. Ledgerwood, Y. Yang et al., "Monocytic suppressive cells mediate cardiovascular transplantation tolerance in mice, "The Journal of Clinical Investigation, vol. 120, no. 7, pp. 2486-2496, 2010.
35. Y. J. Kim, S. Y. Chang, andH. J. Ko, "Myeloid-derived suppressor cells in inflammatory bowel disease, " Intestinal Research, vol. 13, no. 2, pp. 105-111, 2015.
36. L. A. Haile, R. von Wasielewski, J. Gamrekelashvili et al., "Myeloid-derived suppressor cells in inflammatory bowel disease: A new immunoregulatory pathway, " Gastroenterology, vol. 135, no. 3, pp. 871-881, 2008.
37. R. Yang, Z. Cai, Y. Zhang, W. H. Yutzy IV, K. F. Roby, and R. B. S. Roden, "CD80 in immune suppression by mouse ovarian carcinoma-associated Gr-1+CD11b+ myeloid cells, " Cancer Research, vol. 66, no. 13, pp. 6807-6815, 2006.
38. A.-S. Dugast, T. Haudebourg, F. Coulon et al., "Myeloid-derived suppressor cells accumulate in kidney allograft tolerance and specifically suppress effector T cell expansion, " The Journal of Immunology, vol. 180, no. 12, pp. 7898-7906, 2008.
39. N. Dilek, N. Poirier, C. Usal, B. Martinet, G. Blancho, and B. Vanhove, "Control of transplant tolerance and intragraft regulatory T cell localization by Myeloid-derived suppressor cells and CCL5, " Journal of Immunology, vol. 188, no. 9, pp. 4209-4216, 2012.
40. F. Meng, S. Chen, X. Guo et al., "Clinical significance of myeloid-derived suppressor cells in human renal transplantation with acute T cell-mediated rejection, " Inflammation, vol. 37, no. 5, pp. 1799-1805, 2014.
41. B. D. Hock, K. A. Mackenzie, N. B. Cross et al., "Renal transplant recipients have elevated frequencies of circulating myeloidderived suppressor cells, " Nephrology, Dialysis, Transplantation, vol. 27, no. 1, pp. 402-410, 1460.
42. W. Zhang, S. Liang, J. Wu, and A. Horuzsko, "Human inhibitory receptor immunoglobulin-like transcript 2 amplifies CD11b+Gr1+ myeloid-derived suppressor cells that promote long-term survival of allografts, " Transplantation, vol. 86, no. 8, pp. 1125-1134, 2008.
43. V. De Wilde, N. Van Rompaey, M. Hill et al., "Endotoxininduced myeloid-derived suppressor cells inhibit alloimmune responses via heme oxygenase-1, " American Journal of Transplantation, vol. 9, no. 9, pp. 2034-2047, 2009.
44. D. Adeegbe, P. Serafini, V. Bronte, A. Zoso, C. Ricordi, and L. Inverardi, "In vivo induction of myeloid suppressor cells and CD4+foxp3+ T regulatory cells prolongs skin allograft survival in mice, " Cell Transplantation, vol. 20, no. 6, pp. 941-954, 2011.
45. I. Marigo, E. Bosio, S. Solito et al., "Tumor-induced tolerance and immune suppression depend on the C/EBP transcription factor, " Immunity, vol. 32, no. 6, pp. 790-802, 2010.
46. H.-S. Chou, C.-C. Hsieh, R. Charles et al., "Myeloid-derived suppressor cells protect islet transplants by B7-H1 mediated enhancement of T regulatory cells, " Transplantation, vol. 93, no. 3, pp. 272-282, 2012.
47. Y. Arakawa, J. Qin, H.-S. Chou et al., "Cotransplantation with myeloid-derived suppressor cells protects cell transplants: A crucial role of inducible nitric oxide synthase, " Transplantation, vol. 97, no. 7, pp. 740-747, 2014.
48. J. Bryant, N. M. Lerret, J.-J. Wang et al., "Preemptive donor apoptotic cell infusions induce IFN-producing myeloidderived suppressor cells for cardiac allograft protection, " The Journal of Immunology, vol. 192, no. 12, pp. 6092-6101, 2014.
49. T. Nakamura, T. Nakao, N. Yoshimura, and E. Ashihara, "Rapamycin prolongs cardiac allograft survival in a mouse model by inducingmyeloid-derived suppressor cells, " American Journal of Transplantation, vol. 15, no. 9, pp. 2364-2377, 2015.
50. Z. Zhou, D. L. French, G. Ma et al., "Development and function of myeloid-derived suppressor cells generated from mouse embryonic and hematopoietic stem cells, " Stem Cells, vol. 28, no. 3, pp. 620-632, 2010.
51. S. L. Highfill, P. C. Rodriguez, Q. Zhou et al., "Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versushost disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13, " Blood, vol. 116, no. 25, pp. 5738-5747, 2010.
52. D. Wang, Y. Yu, K. Haarberg et al., "Dynamic change and impact of myeloid-derived suppressor cells in allogeneic bone marrow transplantation in mice, " Biology of Blood and Marrow Transplantation, vol. 19, no. 5, pp. 692-702, 2013.